相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Medicinal plants and phytochemicals against multidrug-resistant tumor cells expressing ABCB1, ABCG2, or ABCB5: a synopsis of 2 decades
Thomas Efferth et al.
PHYTOCHEMISTRY REVIEWS (2021)
17-Aminogeldanamycin Inhibits Constitutive Nuclear Factor-Kappa B (NF-κB) Activity in Patient-Derived Melanoma Cell Lines
Mariusz L. Hartman et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
P53 activation suppresses irinotecan metabolite SN-38-induced cell damage in non-malignant but not malignant epithelial colonic cells
Bavani Gunasegaran et al.
TOXICOLOGY IN VITRO (2020)
Broad-spectrum Cross-resistance to Anticancer Drugs Mediated by Epidermal Growth Factor Receptor
Ge Yan et al.
ANTICANCER RESEARCH (2019)
Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells
Raghupathy Vengoji et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Cytotoxicity of ungeremine towards multi-factorial drug resistant cancer cells and induction of apoptosis, ferroptosis, necroptosis and autophagy
Armelle T. Mbaveng et al.
PHYTOMEDICINE (2019)
Multifactorial Modes of Action of Arsenic Trioxide in Cancer Cells as Analyzed by Classical and Network Pharmacology
Mona Dawood et al.
FRONTIERS IN PHARMACOLOGY (2018)
Molecular Determinants of Sensitivity or Resistance of Cancer Cells Toward Sanguinarine
Mohamed E. M. Saeed et al.
FRONTIERS IN PHARMACOLOGY (2018)
Chemosensitivity of human colon cancer cells is influenced by a p53-dependent enhancement of ceramide synthase 5 and induction of autophagy
Sebastian Brachtendorf et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2018)
Novel molecular mechanisms for the adaptogenic effects of herbal extracts on isolated brain cells using systems biology
Alexander Panossian et al.
PHYTOMEDICINE (2018)
Curcumin downregulates expression of opioid-related nociceptin receptor gene (OPRL1) in isolated neuroglia cells
Ean-Jeong Seo et al.
PHYTOMEDICINE (2018)
Cytotoxicity of nimbolide towards multidrug-resistant tumor cells and hypersensitivity via cellular metabolic modulation
Nuha Mahmoud et al.
Oncotarget (2018)
Improved potency of F10 relative to 5-fluorouracil in colorectal cancer cells with p53 mutations
Anthony Dominijanni et al.
CANCER DRUG RESISTANCE (2018)
The role of p53 in cancer drug resistance and targeted chemotherapy
Karin Hientz et al.
ONCOTARGET (2017)
Cytotoxicity of methanol extracts of 10 Cameroonian medicinal plants towards multi-factorial drug-resistant cancer cell lines
Victor Kuete et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2016)
Role of ribosomal protein mutations in tumor development (Review)
Kaveh M. Goudarzi et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
The nonsense-mediated RNA decay pathway is disrupted in inflammatory myofibroblastic tumors
JingWei Lu et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Pharmacogenomics of Scopoletin in Tumor Cells
Ean-Jeong Seo et al.
MOLECULES (2016)
Evaluating ancient Egyptian prescriptions today: Anti-inflammatory activity of Ziziphus spina-christi
Onat Kadioglu et al.
PHYTOMEDICINE (2016)
Comparative analysis of signaling pathways in peripheral blood from patients with Kashin-Beck disease and osteoarthritis
Yujie Ning et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2016)
Cytotoxicity of methanol extracts of Annona muricata, Passiflora edulis and nine other Cameroonian medicinal plants towards multi-factorial drug-resistant cancer cell lines
Victor Kuete et al.
SPRINGERPLUS (2016)
Pharmacogenomic Characterization of Cytotoxic Compounds from Salvia officinalis in Cancer Cells
Onat Kadioglu et al.
JOURNAL OF NATURAL PRODUCTS (2015)
Involvement of AP-1 and NF-κB in the Up-regulation of P-gp in Vinblastine Resistant Caco-2 Cells
Qiuxia Chen et al.
DRUG METABOLISM AND PHARMACOKINETICS (2014)
The ability of molecular docking to unravel the controversy and challenges related to P-glycoprotein-a well-known, yet poorly understood drug transporter
Maen Zeino et al.
INVESTIGATIONAL NEW DRUGS (2014)
NF-κB, an Active Player in Human Cancers
Yifeng Xia et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Targeted inhibition of heat shock protein 90 disrupts multiple oncogenic signaling pathways, thus inducing cell cycle arrest and programmed cell death in human urinary bladder cancer cell lines
Panagiotis K. Karkoulis et al.
CANCER CELL INTERNATIONAL (2013)
Inhibition of heat shock protein 90 (HSP90) as a therapeutic strategy for the treatment of myeloma and other cancers
Paul G. Richardson et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90
Kamalika Moulick et al.
NATURE CHEMICAL BIOLOGY (2011)
Cytotoxic activity of secondary metabolites derived from Artemisia annua L. towards cancer cells in comparison to its designated active constituent artemisinin
Thomas Efferth et al.
PHYTOMEDICINE (2011)
Cistrome: an integrative platform for transcriptional regulation studies
Tao Liu et al.
GENOME BIOLOGY (2011)
Factors determining sensitivity or resistance of tumor cell lines towards artesunate
Serkan Sertel et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2010)
Effect of the hsp90 inhibitor geldanamycin on androgen response of prostate cancer under hypoxic conditions
Yasutomo Suzuki et al.
INTERNATIONAL JOURNAL OF UROLOGY (2010)
NF-kappa B activation mediates resistance to IFN beta in MLL-rearranged acute lymphoblastic leukemia
L. Tracey et al.
LEUKEMIA (2010)
One-pot double intramolecular homolytic aromatic substitution routes to dialicyclic ring fused imidazobenzimidazolequinones and preliminary analysis of anticancer activity
Vincent Fagan et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2010)
NF-κB inhibition triggers death of imatinib-sensitive and imatinib-resistant chronic myeloid leukemia cells including T315I Bcr-Abl mutants
Nadia Lounnas et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Geldanamycin inhibits tyrosine phosphorylation-dependent NF-κB activation
Julie Crevecoeur et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Curcumin down-regulates the multidrug-resistance mdr1b gene by inhibiting the PI3K/Akt/NFκB pathway
Byeong Hyeok Choi et al.
CANCER LETTERS (2008)
Shared principles in NF-κB signaling
Matthew S. Hayden et al.
CELL (2008)
Prediction of broad spectrum resistance of tumors towards anticancer drugs
Thomas Efferth et al.
CLINICAL CANCER RESEARCH (2008)
Blockage of NF-κB by IKKβ- or RelA-siRNA rather than the NF-κB super-suppressor IκBα mutant potentiates adriamycin-induced cytotoxicity in lung cancer cells
Wenshu Chen et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Quantitative imaging assay for NF-kappa B nuclear translocation in primary human macrophages
Mahdad Noursadeghi et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2008)
The 90-kDa heat shock protein stabilizes the polysomal ribonuclease 1 mRNA endonuclease to degradation by the 26S proteasome
Yong Peng et al.
MOLECULAR BIOLOGY OF THE CELL (2008)
Cisplatin abrogates the geldanamycin-induced heat shock response
Andrea K. McCollum et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Active roles for inhibitory κB kinases α and β in nuclear factor-κB-mediated chemoresistance to doxorubicin
Brian K. Bednarski et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Hsp90 inhibition has opposing effects on wild-type and mutant p53 and induces p21 expression and cytotoxicity irrespective of p53/ATM status in chronic lymphocytic leukaemia cells
K. Lin et al.
ONCOGENE (2008)
Glut-1 as a therapeutic target: increased chemoresistance and HIF-1-independent link with cell turnover is revealed through COMPARE analysis and metabolomic studies
Andrew Evans et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
Induction of epidermal growth factor receptor expression by Epstein-Barr virus latent membrane protein 1 c-terminal-activating region 1 is mediated by NF-κB p50 Homodimer/Bcl-3 complexes
Natalie J. Thornburg et al.
JOURNAL OF VIROLOGY (2007)
ErbB receptors: from oncogenes to targeted cancer therapies
Hongtao Zhang et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Reactive oxygen species activate the HIF-1α promoter via a functional NFκB site
Steve Bonello et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Pharmacologic activation of p53-dependent and p53-independent apoptotic pathways in Hodgkin/Reed-Sternberg cells
M. Janz et al.
LEUKEMIA (2007)
Inhibitors of NF-κB signaling:: 785 and counting
T. D. Gilmore et al.
ONCOGENE (2006)
Mammalian target of rapamycin inhibition promotes response to epidermal growth factor receptor kinase inhibitors in PTEN-Deficient and PTEN-intact glioblastoma cells
Maria Y. Wang et al.
CANCER RESEARCH (2006)
Comparison of 17-dimethylaminoethylamino-17-demethoxy-geldanamycin (17DMAG) and 17-allylamino-17-demethoxygeldanamycin (17AAG) in vitro: effects on Hsp90 and client proteins in melanoma models
V Smith et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2005)
Epidermal growth factor receptors harboring kinase domain mutations associate with the heat shock protein 90 chaperone and are destabilized following exposure to geldanamycins
T Shimamura et al.
CANCER RESEARCH (2005)
Pharmacokinetics and pharmacodynamics of 17-demethoxy 17-[[(2-dimethylamino)ethyl]amino]geldanamycin (17DMAG, NSC 707545) in C.B-17 SCID mice bearing MDA-MB-231 human breast cancer xenografts
JL Eiseman et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2005)
Hsp90 inhibitor geldanamycin and its derivatives as novel cancer chemotherapeutic agents
Y Miyata
CURRENT PHARMACEUTICAL DESIGN (2005)
Combination-treatment of glioblastoma multiforme cell lines with the anti-malarial artesunate and the epidermal growth factor receptor tyrosine kinase inhibitor OSI-774
T Efferth et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Characterization of p53 wild-type and null isogenic colorectal cancer cell lines resistant to 5-fluorouracil, oxaliplatin, and irinotecan
J Boyer et al.
CLINICAL CANCER RESEARCH (2004)
CHIP: a quality-control E3 ligase collaborating with molecular chaperones
S Murata et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2003)
Role of the NF-κ13 signaling pathway and κB cis-regulatory elements on the IRF-1 and iNOS promoter regions in mycobacterial lipoarabinomannan induction of nitric oxide
KR Morris et al.
INFECTION AND IMMUNITY (2003)
Heat shock protein 90 as a molecular target for cancer therapeutics
JS Isaacs et al.
CANCER CELL (2003)
NF-κB transcription factor induces drug resistance through MDR1 expression in cancer cells
M Bentires-Alj et al.
ONCOGENE (2003)
Natural Product Origins of Hsp90 Inhibitors
Yoshimasa Uehara
CURRENT CANCER DRUG TARGETS (2003)
Silibinin inhibits constitutive and TNFα-induced activation of NF-αB and sensitizes human prostate carcinoma DU145 cells to TNFα-induced apoptosis
S Dhanalakshmi et al.
ONCOGENE (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Transcriptional regulation of bcl-2 by nuclear factor κB and its significance in prostate cancer
SD Catz et al.
ONCOGENE (2001)
Geldanamycin inhibits NF-κB activation and interleukin-8 gene expression in cultured human respiratory epithelium
V Malhotra et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2001)
A gene expression database for the molecular pharmacology of cancer
U Scherf et al.
NATURE GENETICS (2000)
The Protein Data Bank
HM Berman et al.
NUCLEIC ACIDS RESEARCH (2000)
Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity
J O'Brien et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2000)
分享论文
